세포 투과성 펩티드(CPP) 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 15.2%의 성장률로 38억 1,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 희귀질환에 대한 새로운 펩타이드 기반 치료제 개발, 신흥국 시장의 헬스케어 인프라에 대한 투자 확대, 펩타이드 기반 백신 및 면역 요법에 대한 수요 증가, 펩타이드 의약품 승인 절차를 간소화하려는 규제 당국의 노력, 지속 가능하고 생분해성이 높은 펩타이드 전달 시스템으로의 전환 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 특정 치료 용도를 위한 세포 내 침투 펩타이드의 맞춤화, 세포 내 전달 도구로서의 세포 내 침투 펩타이드의 탐구, 펩타이드 설계에 인공지능과 머신러닝의 통합, 세포 내 침투 펩타이드의 통합, 새로운 전달 경로의 채택 등이 있습니다.
세포침투 펩타이드 시장의 성장은 건강 연구개발(R&:D)에 대한 투자 증가에 의해 주도될 것으로 예측됩니다. 건강 R&:D는 과학적 이해를 증진하고 더 나은 의료 결과를 위한 혁신적인 솔루션을 개발하기 위한 체계적인 연구와 실험을 포함합니다. 이러한 R&D 투자 증가는 의료 수요, 기술 발전, 세계 보건 우선순위, 투자 인센티브, 경제적 기회에 의해 촉진됩니다. 세포투과성 펩타이드는 특히 약물 전달, 유전자 치료, 백신 개발, 분자 이미징, 세포 연구 등 건강 R&&D를 촉진하는 데 중요한 역할을 합니다. 예를 들어, 2023년 12월 미국 주정부 기관은 2022 회계연도에 11억 달러를 보건 연구개발비로 배정하여 2021 회계연도의 10억 7,000만 달러에서 2.2% 증가하였습니다. 따라서 연구 개발 활동 증가는 세포 침입 펩타이드 시장의 성장을 가속하고 있습니다.
세포침투 펩타이드 시장의 주요 기업들은 경쟁 우위를 확보하기 위해 펩타이드 신약개발 플랫폼과 같은 혁신적인 플랫폼에 집중하고 있습니다. 이러한 플랫폼은 CPP 기반 치료제의 식별, 설계, 최적화 및 평가를 효율화합니다. 예를 들어, 후지쯔 주식회사는 2023년 5월에 Biodrug Design Accelerator를 발표했는데, Biodrug Design Accelerator는 제약회사의 펩타이드 신약개발 과학자들을 지원하는 플랫폼으로, 특히 '설계, 제조, 시험, 분석(DMTA)'(Design, Manufacturing, Testing, Analysis) 사이클을 통해 펩타이드 의약품 개발의 신속성과 효율화를 실현합니다. 복잡한 생체분자를 기술하기 위한 방법론인 HELM과 호환되며, 합성 및 시험에 대한 과학자 간의 커뮤니케이션을 촉진합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 세포 투과성 펩티드 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 세포 투과성 펩티드(CPP) 시장 : 성장률 분석
- 세계의 세포 투과성 펩티드(CPP) 시장 실적 : 규모와 성장, 2019-2024
- 세계의 세포 투과성 펩티드(CPP) 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 세포 투과성 펩티드 전체 시장(TAM)
제6장 시장 세분화
- 세계의 세포 투과성 펩티드(CPP) 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 합성 세포 투과 펩티드
- 단백질 유래 세포 투과 펩티드
- 키메라 세포 투과 펩티드
- 세계의 세포 투과성 펩티드(CPP) 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 약물전달
- 유전자 전달
- 진단
- 분자 이미징
- 기타 용도
- 세계의 세포 투과성 펩티드(CPP) 시장 : 최종 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 제약 및 바이오테크놀러지 기업
- 계약연구기관(CRO)
- 병원 및 진료소
- 기타 최종사용자
- 세계의 세포 투과성 펩티드(CPP) 시장 : 합성 세포 투과 펩티드 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Linear Synthetic CPPs
- Branched Synthetic CPPs
- Peptide Conjugates
- Lipid-Modified Synthetic CPPs
- 세계의 세포 투과성 펩티드(CPP) 시장 단백질 유래 세포 투과 펩티드 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Tat Peptides (From HIV-1 TAT)
- Antennapedia Peptides
- Homeodomain Peptides
- Other Naturally Derived CPPs
- 세계의 세포 투과성 펩티드(CPP) 시장 키메라 세포 투과 펩티드 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 융합 펩티드
- 하이브리드 펩티드
제7장 지역별/국가별 분석
- 세계의 세포 투과성 펩티드(CPP) 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 세포 투과성 펩티드(CPP) 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 세포 투과성 펩티드(CPP) 시장 : 경쟁 구도
- 세포 투과성 펩티드(CPP) 시장 : 기업 개요
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
- Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- Corden Pharma GmbH Overview, Products and Services, Strategy and Financial Analysis
- Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- GenScript Biotech Corporation
- Bachem Holding AG
- R&D Systems Inc.
- PolyPeptide Laboratories AB
- PeptiDream Inc.
- Revance Therapeutics Inc.
- CPC Scientific Inc.
- Tocris Bioscience
- Bio-Synthesis Inc.
- AnaSpec Inc.
- Avidity Biosciences Inc.
- Iris Biotech GmbH
- PEPperPRINT GmbH
- Chemos GmbH & Co. KG
- Creative Peptides GmbH
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 세포 투과성 펩티드(CPP) 시장(2029년) : 새로운 기회를 제공하는 국가
- 세포 투과성 펩티드(CPP) 시장(2029년) : 새로운 기회를 제공하는 부문
- 세포 투과성 펩티드(CPP) 시장(2029년) : 성장 전략
제36장 부록
LSH
Cell-penetrating peptides (CPPs), also referred to as protein transduction domains (PTDs) or membrane translocation peptides, are short peptides typically comprising 5 to 30 amino acids. They possess the capability to traverse cell membranes and facilitate the intracellular delivery of diverse cargo molecules, including proteins, nucleic acids, and small molecules. These peptides enable the transport of various cargoes across biological barriers such as the plasma membrane, endosomal membranes, and nuclear envelope, without causing significant cellular damage.
The primary types of cell-penetrating peptides include synthetic cell-penetrating peptides, protein-derived cell-penetrating peptides, and chimeric cell-penetrating peptides. Synthetic cell-penetrating peptides are artificially created in laboratory settings, often through chemical synthesis methods. These peptides find applications in drug delivery, gene delivery, diagnostics, molecular imaging, and other pharmaceutical and biotechnology-related applications, catering to entities such as pharmaceutical and biotechnology companies, contract research organizations (CROs), hospitals and clinics, among others.
The cell-penetrating peptide market research report is one of a series of new reports from The Business Research Company that provides cell-penetrating peptide market statistics, including cell-penetrating peptide industry global market size, regional shares, competitors with cell-penetrating peptide market share, detailed cell-penetrating peptide market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-penetrating peptide industry. This cell-penetrating peptide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell penetrating peptide market size has grown rapidly in recent years. It will grow from $1.87 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to increased understanding of cellular uptake mechanisms, growth in demand for targeted drug delivery systems, rising prevalence of chronic diseases, emergence of personalized medicine approaches, and expansion of pharmaceutical research and development.
The cell penetrating peptide market size is expected to see rapid growth in the next few years. It will grow to $3.81 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to development of novel peptide-based therapeutics for rare diseases, growing investment in healthcare infrastructure in emerging markets, rising demand for peptide-based vaccines and immunotherapies, regulatory initiatives to streamline approval processes for peptide drugs, and shift towards sustainable and biodegradable peptide delivery systems. Major trends in the forecast period include customization of cell penetration peptides for specific therapeutic applications, exploration of cell-penetrating peptides as tools for intracellular delivery, integration of artificial intelligence and machine learning in peptide design, integration of cell-penetrating peptides, and adoption of novel delivery routes.
The growth of the cell penetration peptide market is expected to be driven by increasing investment in health research and development (R&D). Health R&D involves systematic exploration and experimentation to advance scientific understanding and develop innovative solutions for better healthcare outcomes. This increase in R&D investment is fueled by healthcare needs, technological advancements, global health priorities, investment incentives, and economic opportunities. Cell penetration peptides play a crucial role in advancing health R&D, particularly in drug delivery, gene therapy, vaccine development, molecular imaging, and cellular research. For example, in December 2023, state government agencies in the US allocated $1.10 billion towards health R&D in fiscal year 2022, marking a 2.2% increase from fiscal year 2021's $1.07 billion expenditure. Hence, the rise in R&D activities is propelling the growth of the cell penetration peptide market.
Key players in the cell penetration peptide market are focusing on innovative platforms such as peptide drug discovery platforms to gain a competitive advantage. These platforms streamline the identification, design, optimization, and evaluation of CPP-based therapeutics. For instance, in May 2023, Fujitsu Limited introduced the Biodrug Design Accelerator, a platform aiding peptide drug discovery scientists in pharmaceutical firms by expediting and enhancing the efficiency of peptide drug development, particularly through the 'design, make, test, analyze' (DMTA) cycles. It facilitates communication among scientists regarding synthesis and testing, compatible with HELM, a method for describing complex biomolecules.
In December 2023, Invaio Sciences, a US company specializing in human health and digital innovation solutions, acquired Peptyde Bio for an undisclosed sum. This acquisition equips Invaio with a strong platform and intellectual property portfolio, enabling the company to expedite the development and discovery of biologically active peptides. Peptyde Bio, also based in the US, focuses on discovering, designing, and characterizing novel cell-penetrating peptides.
Major companies operating in the cell penetrating peptide market are Thermo Fisher Scientific Inc., Novo Nordisk A/S, Merck KGaA, Corden Pharma GmbH, Sarepta Therapeutics Inc., GenScript Biotech Corporation, Bachem Holding AG, R&D Systems Inc., PolyPeptide Laboratories AB, PeptiDream Inc., Revance Therapeutics Inc., CPC Scientific Inc., Tocris Bioscience, Bio-Synthesis Inc., AnaSpec Inc., Avidity Biosciences Inc., Iris Biotech GmbH, PEPperPRINT GmbH, Chemos GmbH & Co. KG, Creative Peptides GmbH, ProImmune Ltd., Pepscan Inc., The Cupid Peptide Company, AltaBioscience Ltd., Peptomyc
North America was the largest region in the cell penetrating peptide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell penetrating peptide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell penetrating peptide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell-penetrating peptide market consists of revenues earned by entities by providing services such as custom synthesis services, peptide conjugation services, preclinical and clinical testing services, and delivery system development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell penetrating peptide market also includes sales of automated peptide synthesizers, mass spectrometers, fluorescence microscopes, and flow cytometers which are used in providing cell penetrating peptide services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Penetrating Peptide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell penetrating peptide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell penetrating peptide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell penetrating peptide market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Synthetic Cell Penetrating Peptides; Protein-Derived Cell Penetrating Peptides; Chimeric Cell Penetrating Peptides
- 2) By Application: Drug Delivery; Gene Delivery; Diagnostics; Molecular Imaging; Other Applications
- 3) By End Use: Pharmaceutical And Biotechnology Companies; Contract Research Organization (CROs); Hospitals And Clinics; Others End Users
- Subsegments:
- 1) By Synthetic Cell Penetrating Peptides: Linear Synthetic CPPs; Branched Synthetic CPPs; Peptide Conjugates; Lipid-Modified Synthetic CPPs
- 2) By Protein-Derived Cell Penetrating Peptides: Tat Peptides (From HIV-1 TAT); Antennapedia Peptides; Homeodomain Peptides; Other Naturally Derived CPPs
- 3) By Chimeric Cell Penetrating Peptides: Fusion Peptides; Hybrid Peptides
- Companies Mentioned: Thermo Fisher Scientific Inc.; Novo Nordisk A/S; Merck KGaA; Corden Pharma GmbH; Sarepta Therapeutics Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cell Penetrating Peptide Market Characteristics
3. Cell Penetrating Peptide Market Trends And Strategies
4. Cell Penetrating Peptide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cell Penetrating Peptide Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cell Penetrating Peptide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cell Penetrating Peptide Market Growth Rate Analysis
- 5.4. Global Cell Penetrating Peptide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cell Penetrating Peptide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cell Penetrating Peptide Total Addressable Market (TAM)
6. Cell Penetrating Peptide Market Segmentation
- 6.1. Global Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Synthetic Cell Penetrating Peptides
- Protein-Derived Cell Penetrating Peptides
- Chimeric Cell Penetrating Peptides
- 6.2. Global Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Delivery
- Gene Delivery
- Diagnostics
- Molecular Imaging
- Other Applications
- 6.3. Global Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical And Biotechnology Companies
- Contract Research Organization (CROs)
- Hospitals And Clinics
- Others End Users
- 6.4. Global Cell Penetrating Peptide Market, Sub-Segmentation Of Synthetic Cell Penetrating Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Linear Synthetic CPPs
- Branched Synthetic CPPs
- Peptide Conjugates
- Lipid-Modified Synthetic CPPs
- 6.5. Global Cell Penetrating Peptide Market, Sub-Segmentation Of Protein-Derived Cell Penetrating Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tat Peptides (From HIV-1 TAT)
- Antennapedia Peptides
- Homeodomain Peptides
- Other Naturally Derived CPPs
- 6.6. Global Cell Penetrating Peptide Market, Sub-Segmentation Of Chimeric Cell Penetrating Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Fusion Peptides
- Hybrid Peptides
7. Cell Penetrating Peptide Market Regional And Country Analysis
- 7.1. Global Cell Penetrating Peptide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cell Penetrating Peptide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cell Penetrating Peptide Market
- 8.1. Asia-Pacific Cell Penetrating Peptide Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cell Penetrating Peptide Market
- 9.1. China Cell Penetrating Peptide Market Overview
- 9.2. China Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cell Penetrating Peptide Market
- 10.1. India Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cell Penetrating Peptide Market
- 11.1. Japan Cell Penetrating Peptide Market Overview
- 11.2. Japan Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cell Penetrating Peptide Market
- 12.1. Australia Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cell Penetrating Peptide Market
- 13.1. Indonesia Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cell Penetrating Peptide Market
- 14.1. South Korea Cell Penetrating Peptide Market Overview
- 14.2. South Korea Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cell Penetrating Peptide Market
- 15.1. Western Europe Cell Penetrating Peptide Market Overview
- 15.2. Western Europe Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cell Penetrating Peptide Market
- 16.1. UK Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cell Penetrating Peptide Market
- 17.1. Germany Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cell Penetrating Peptide Market
- 18.1. France Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cell Penetrating Peptide Market
- 19.1. Italy Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cell Penetrating Peptide Market
- 20.1. Spain Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cell Penetrating Peptide Market
- 21.1. Eastern Europe Cell Penetrating Peptide Market Overview
- 21.2. Eastern Europe Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cell Penetrating Peptide Market
- 22.1. Russia Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cell Penetrating Peptide Market
- 23.1. North America Cell Penetrating Peptide Market Overview
- 23.2. North America Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cell Penetrating Peptide Market
- 24.1. USA Cell Penetrating Peptide Market Overview
- 24.2. USA Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cell Penetrating Peptide Market
- 25.1. Canada Cell Penetrating Peptide Market Overview
- 25.2. Canada Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cell Penetrating Peptide Market
- 26.1. South America Cell Penetrating Peptide Market Overview
- 26.2. South America Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cell Penetrating Peptide Market
- 27.1. Brazil Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cell Penetrating Peptide Market
- 28.1. Middle East Cell Penetrating Peptide Market Overview
- 28.2. Middle East Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cell Penetrating Peptide Market
- 29.1. Africa Cell Penetrating Peptide Market Overview
- 29.2. Africa Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cell Penetrating Peptide Market Competitive Landscape And Company Profiles
- 30.1. Cell Penetrating Peptide Market Competitive Landscape
- 30.2. Cell Penetrating Peptide Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Corden Pharma GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Cell Penetrating Peptide Market Other Major And Innovative Companies
- 31.1. GenScript Biotech Corporation
- 31.2. Bachem Holding AG
- 31.3. R&D Systems Inc.
- 31.4. PolyPeptide Laboratories AB
- 31.5. PeptiDream Inc.
- 31.6. Revance Therapeutics Inc.
- 31.7. CPC Scientific Inc.
- 31.8. Tocris Bioscience
- 31.9. Bio-Synthesis Inc.
- 31.10. AnaSpec Inc.
- 31.11. Avidity Biosciences Inc.
- 31.12. Iris Biotech GmbH
- 31.13. PEPperPRINT GmbH
- 31.14. Chemos GmbH & Co. KG
- 31.15. Creative Peptides GmbH
32. Global Cell Penetrating Peptide Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cell Penetrating Peptide Market
34. Recent Developments In The Cell Penetrating Peptide Market
35. Cell Penetrating Peptide Market High Potential Countries, Segments and Strategies
- 35.1 Cell Penetrating Peptide Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cell Penetrating Peptide Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cell Penetrating Peptide Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
